Annual Accounts Receivable
$90.61 M
-$6.57 M-6.76%
31 March 2022
Summary:
Abiomed annual accounts receivable is currently $90.61 million, with the most recent change of -$6.57 million (-6.76%) on 31 March 2022. During the last 3 years, it has fallen by -$6.57 million (-6.76%).ABMD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$94.47 M
+$3.37 M+3.70%
30 September 2022
Summary:
Abiomed quarterly accounts receivable is currently $94.47 million, with the most recent change of +$3.37 million (+3.70%) on 30 September 2022.ABMD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABMD Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -6.8% | +6.2% |
5 y5 years | -0.2% | -6.5% |
ABMD Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -6.8% | -6.5% |
Abiomed Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $94.47 M(+3.7%) |
June 2022 | - | $91.10 M(+0.5%) |
Mar 2022 | $90.61 M(-6.8%) | $90.61 M(+1.9%) |
Dec 2021 | - | $88.95 M(-0.7%) |
Sept 2021 | - | $89.57 M(+1.0%) |
June 2021 | - | $88.64 M(-8.8%) |
Mar 2021 | $97.18 M(+14.8%) | $97.18 M(+4.5%) |
Dec 2020 | - | $92.99 M(+14.9%) |
Sept 2020 | - | $80.91 M(-1.4%) |
June 2020 | - | $82.08 M(-3.0%) |
Mar 2020 | $84.65 M(-6.8%) | $84.65 M(-16.2%) |
Dec 2019 | - | $100.99 M(+7.1%) |
Sept 2019 | - | $94.32 M(+9.4%) |
June 2019 | - | $86.21 M(-5.1%) |
Mar 2019 | $90.81 M(+29.7%) | $90.81 M(+2.9%) |
Dec 2018 | - | $88.22 M(+18.9%) |
Sept 2018 | - | $74.20 M(+9.9%) |
June 2018 | - | $67.51 M(-3.6%) |
Mar 2018 | $70.01 M(+29.5%) | $70.01 M(+7.9%) |
Dec 2017 | - | $64.86 M(+13.1%) |
Sept 2017 | - | $57.33 M(+7.0%) |
June 2017 | - | $53.56 M(-0.9%) |
Mar 2017 | $54.05 M(+26.2%) | $54.05 M(+7.7%) |
Dec 2016 | - | $50.18 M(+7.7%) |
Sept 2016 | - | $46.61 M(+12.9%) |
June 2016 | - | $41.28 M(-3.6%) |
Mar 2016 | $42.82 M(+34.5%) | $42.82 M(+16.2%) |
Dec 2015 | - | $36.84 M(-0.7%) |
Sept 2015 | - | $37.12 M(+8.0%) |
June 2015 | - | $34.37 M(+8.0%) |
Mar 2015 | $31.83 M(+30.7%) | $31.83 M(+12.2%) |
Dec 2014 | - | $28.37 M(+23.0%) |
Sept 2014 | - | $23.07 M(+1.4%) |
June 2014 | - | $22.76 M(-6.5%) |
Mar 2014 | $24.36 M(+6.1%) | $24.36 M(+6.1%) |
Dec 2013 | - | $22.96 M(+8.7%) |
Sept 2013 | - | $21.12 M(+0.6%) |
June 2013 | - | $20.98 M(-8.6%) |
Mar 2013 | $22.95 M(+12.2%) | $22.95 M(+15.2%) |
Dec 2012 | - | $19.91 M(+5.9%) |
Sept 2012 | - | $18.80 M(+2.5%) |
June 2012 | - | $18.34 M(-10.3%) |
Mar 2012 | $20.46 M(+33.1%) | $20.46 M(+18.2%) |
Dec 2011 | - | $17.30 M(+11.7%) |
Sept 2011 | - | $15.49 M(+6.5%) |
June 2011 | - | $14.54 M(-5.4%) |
Mar 2011 | $15.38 M(+13.8%) | $15.38 M(+19.5%) |
Dec 2010 | - | $12.87 M(-14.1%) |
Sept 2010 | - | $14.99 M(+19.2%) |
June 2010 | - | $12.57 M(-7.0%) |
Mar 2010 | $13.52 M(-14.0%) | $13.52 M(-6.1%) |
Dec 2009 | - | $14.40 M(+7.4%) |
Sept 2009 | - | $13.40 M(-7.4%) |
June 2009 | - | $14.48 M(-7.9%) |
Mar 2009 | $15.72 M | $15.72 M(+11.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2008 | - | $14.17 M(-3.0%) |
Sept 2008 | - | $14.60 M(+5.2%) |
June 2008 | - | $13.88 M(-1.3%) |
Mar 2008 | $14.07 M(+28.7%) | $14.07 M(+20.5%) |
Dec 2007 | - | $11.68 M(+35.6%) |
Sept 2007 | - | $8.62 M(-37.7%) |
June 2007 | - | $13.83 M(+26.5%) |
Mar 2007 | $10.93 M(+23.1%) | $10.93 M(+18.4%) |
Dec 2006 | - | $9.23 M(+11.2%) |
Sept 2006 | - | $8.30 M(-14.2%) |
June 2006 | - | $9.68 M(+9.0%) |
Mar 2006 | $8.88 M(+2.8%) | $8.88 M(+5.5%) |
Dec 2005 | - | $8.42 M(+6.0%) |
Sept 2005 | - | $7.94 M(+11.6%) |
June 2005 | - | $7.11 M(-17.6%) |
Mar 2005 | $8.63 M(+44.6%) | $8.63 M(+17.9%) |
Dec 2004 | - | $7.32 M(+7.9%) |
Sept 2004 | - | $6.79 M(+25.3%) |
June 2004 | - | $5.42 M(-9.3%) |
Mar 2004 | $5.97 M(+14.3%) | $5.97 M(+55.0%) |
Dec 2003 | - | $3.85 M(+15.0%) |
Sept 2003 | - | $3.35 M(-21.6%) |
June 2003 | - | $4.27 M(-18.2%) |
Mar 2003 | $5.22 M(-26.0%) | $5.22 M(+20.1%) |
Dec 2002 | - | $4.35 M(-19.5%) |
Sept 2002 | - | $5.41 M(-17.5%) |
June 2002 | - | $6.55 M(-7.1%) |
Mar 2002 | $7.06 M(-29.6%) | $7.06 M(+27.1%) |
Dec 2001 | - | $5.55 M(-2.5%) |
Sept 2001 | - | $5.70 M(-28.8%) |
June 2001 | - | $8.00 M(-20.2%) |
Mar 2001 | $10.03 M(+49.9%) | $10.03 M(+18.5%) |
Dec 2000 | - | $8.46 M(+5.1%) |
Sept 2000 | - | $8.05 M(+23.9%) |
June 2000 | - | $6.49 M(-2.9%) |
Mar 2000 | $6.69 M(+4.5%) | $6.69 M(-2.5%) |
Dec 1999 | - | $6.86 M(-0.8%) |
Sept 1999 | - | $6.92 M(-11.1%) |
June 1999 | - | $7.78 M(+21.6%) |
Mar 1999 | $6.40 M(+18.5%) | $6.40 M(+23.1%) |
Dec 1998 | - | $5.20 M(+4.9%) |
Sept 1998 | - | $4.95 M(-20.2%) |
June 1998 | - | $6.21 M(+15.0%) |
Mar 1998 | $5.40 M(+12.5%) | $5.40 M(+17.5%) |
Dec 1997 | - | $4.59 M(-26.6%) |
Sept 1997 | - | $6.26 M(+6.8%) |
June 1997 | - | $5.86 M(+22.1%) |
Mar 1997 | $4.80 M(+84.2%) | $4.80 M(+49.4%) |
Dec 1996 | - | $3.21 M(+9.2%) |
Sept 1996 | - | $2.94 M(+22.0%) |
June 1996 | - | $2.41 M(-7.5%) |
Mar 1996 | $2.61 M(+44.8%) | $2.61 M(+9.6%) |
Dec 1995 | - | $2.38 M(+1.6%) |
Sept 1995 | - | $2.34 M(+16.2%) |
June 1995 | - | $2.01 M(+11.9%) |
Mar 1995 | $1.80 M | $1.80 M |
FAQ
- What is Abiomed annual accounts receivable?
- What is the all time high annual accounts receivable for Abiomed?
- What is Abiomed quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Abiomed?
What is Abiomed annual accounts receivable?
The current annual accounts receivable of ABMD is $90.61 M
What is the all time high annual accounts receivable for Abiomed?
Abiomed all-time high annual accounts receivable is $97.18 M
What is Abiomed quarterly accounts receivable?
The current quarterly accounts receivable of ABMD is $94.47 M
What is the all time high quarterly accounts receivable for Abiomed?
Abiomed all-time high quarterly accounts receivable is $100.99 M